Illumina Releases 2022 Corporate Social Responsibility Report Highlighting Contributions to Global Health and Sustainability

The report emphasized the contributions of genomics in promoting public health and global health.

ShanghaiJune 2, 2022PR Newswire -- As the 51st World Environment Day approaches, Illumina, Inc., the global leader in genome sequencing and array technology, officially released the Chinese version of its 2022 Corporate Social Responsibility Report. The report highlights the progress of the company's 2021 Environmental, Social, and Governance (ESG) initiatives, demonstrating Illumina's steadfast commitment to "improving human health" and its active role as a guardian for patients, communities, humanity, and the planet.

Illumina, Inc. 2022 Corporate Social Responsibility Report (Chinese Version) Officially Released

"Over the past year, we have remained steadfast in addressing the COVID-19 pandemic, enhancing the accessibility and equity of genomics, and protecting our planet. Throughout this journey, we have witnessed countless stories of resilience, determination, and ambition. With our advanced technologies, we have empowered researchers and clinicians to identify appropriate solutions for some of the world’s most pressing challenges," said Francis deSouza, CEO of Illumina, Inc. "Looking ahead, we will focus on harnessing the power of genomics to continue making a positive impact on the world, creating a more sustainable, equitable, and healthier future for all humanity."

The report outlines Illumina's efforts in ESG, covering key areas such as expanding access to genomics, empowering communities, integrating environmental sustainability, cultivating employees, and responsible operations. It highlights significant progress achieved by the company in these focus areas in 2021: benefiting 1 billion people through genetic testing, donating over $14.5 million to support more than 1,300 charitable causes, sourcing 59% of global operational electricity from renewable energy, committing to achieve net-zero emissions across the entire value chain by 2050, maintaining a zero net pay gap, and increasing the percentage of female executives by 5% over the past three years.

In China, Illumina, as a leader in the field of genomics, continues to make efforts in empowering the ecosystem, giving back to society, and caring for employees. It actively fulfills its corporate social responsibility and injects vitality into the development of China's genetic testing industry.

In 2021, Illumina facilitated the establishment of the Genetic Testing Industry Alliance (Shanghai), collaborating with nearly 60 upstream and downstream organizations to enhance industrial capabilities; organized the Illumina China NGS Industry Summit, bringing together over 300 leading scientists, researchers, founders, and investors in the field to jointly discuss and build the future of the industry; partnered with Sequoia China to launch the Sequoia China Intelligent Healthcare Genomics Incubator (powered by Illumina technology), empowering local innovation through collaboration. Meanwhile, Illumina continued to strengthen genomics education, supporting educational programs that reached 11,000 healthcare professionals across Greater China in the past year, providing them with technical support and promoting the development of precision medicine.

In terms of giving back to society, Illumina, Inc. promptly initiated an internal donation drive in response to the sudden severe rainstorm in Henan, directing aid to the families of flood-fighting heroes. Within the company's culture that advocates care and回馈, employees in Beijing have spontaneously organized activities for four consecutive years to accompany children with autism, bringing warmth to these "children of the stars" and their families.

In 2021, Illumina, Inc. further expanded its gene knowledge popularization efforts in China. Illumina hosted a Family Day (STEM Experience Day) event for employees to spark curiosity and interest in the younger generation; Illumina also collaborated with renowned KOLs to create engaging and educational comics and videos, enhancing public awareness of genomic sequencing and its value.

Employee care is also an important component of Illumina's global strategy for fulfilling corporate social responsibility in China. While continuously supporting employees' career development, Illumina places a strong emphasis on creating a healthier and safer work environment for employees in China. During the 2021 China Production Safety Month, the company’s internal Safety Week event further reinforced employees' safety awareness and first aid skills.

"Illumina’s corporate social responsibility initiatives in China are continuously thriving, thanks to the unwavering support from external partners and internal employees who share our values and sense of responsibility," said Li Qing, Senior Vice President of Illumina and General Manager of Greater China. "In the future, we will join hands with more like-minded individuals to ensure that 'Genomics for Good' takes root, blossoms, and creates lasting value for more lives on this land."

To read the full report, please visitIllumina Official Website CSR Section。